[Magdalen] Today, PCP appt.

[Lynn Ronkainen]

I think they've been tweaked enough to reduce early symptoms and more than a few years out mfgs can deny involvement of Rx
Lynn

Sent from my iPhone

On Jul 15, 2016, at 10:50 AM, Cantor03--- via Magdalen <magdalen at herberthouse.org> wrote:



In a message dated 7/15/2016 11:27:21 A.M. Eastern Daylight Time,  
jay.weigel at gmail.com writes:

Copy,  print and take to your doctor,  Allan.>>>>>>>>>>>>>>>>>>>


With disabling neuropathy this is good advice to cover all the bases.

However, 14 years have passed since this article, and if the statins  were
an important neuropathic disabler, their use would have been long  since
severely curtailed.

I suppose through the years I saw thousands of patients with elevated  
lipids,
and I got the distinct impression that if statins were  discontinued for 
whatever reason, it was very difficult to reproduce their therapeutic 
effect on the lipids with another scheme.  

So if there is any message here is that I would be very, very sure  that
bothersome symptoms are due to the statins before they are  discontinued,
and that is especially true for diabetics.

The statins have made their economic impact on the practice of
dermatology.  I used to have the easy surgical removal of  xanthelasmas
as one of my "bread and butter" procedures, but in the last 15 years  or
so of practice, the occurrence of these dried up completely.   Patients
no longer had hyperlipidemia because they were all taking statins,
and they no longer had xanthelasmata.


David Strang.